It was viewed, and Jenkins did discuss this, as the least efficient, the least stimulative part of the SR and ED R and D program. That's why we took it out.
It's important to realize that this isn't a dramatic huge change. This is reducing a 20% SR and ED investment tax credit to 15% of qualified expenditures. That's what it is. And it does not apply on the first $3 million of qualified SR and ED expenditures annually.
This is a benefit for smaller businesses that are innovative in R and D. Yes, it's not as popular, no doubt, with some of the large businesses doing R and D in Canada, but to suggest that that 5% difference is going to be the difference between doing R and D in Canada and not, with respect, I think is a bit of a stretch.